Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Industry

Stocks like Universal Health Services Inc. [UHS] still have plenty of sunny days ahead

January 20, 2023
in Industry

In yesterday’s Wall Street session, Universal Health Services Inc. (NYSE:UHS) shares traded at $146.29, up 0.44% from the previous session.

As of this writing, 18 analysts cover Universal Health Services Inc. (NYSE:UHS). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $168.00 and a low of $113.00, we find $138.00. Given the previous closing price of $145.65, this indicates a potential downside of -5.25 percent. UHS stock price is now 9.67% away from the 50-day moving average and 24.88% away from the 200-day moving average. The market capitalization of the company currently stands at $10.33B.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

There are 9 analysts who have given it a hold rating, whereas 5 have given it a buy rating. Brokers who have rated the stock have averaged $138.88 as their price target over the next twelve months.

With the price target enhanced from $113 to $154, Wells Fargo Upgraded its rating from Underweight to Equal Weight for Universal Health Services Inc. (NYSE: UHS). On December 16, 2022, BofA Securities Upgraded its previous ‘Underperform’ rating to ‘Neutral’ on the stock increasing its target price from $120 to quote $145, while ‘BMO Capital Markets’ rates the stock as ‘Underperform’.

In other news, Gibbs Lawrence S., Director sold 1,307 shares of the company’s stock on Mar 11. The stock was sold for $199,971 at an average price of $153.00. Upon completion of the transaction, the Director now directly owns 1,869 shares in the company, valued at $0.27 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 01, Director Gibbs Lawrence S. sold 985 shares of the business’s stock. A total of $141,682 was realized by selling the stock at an average price of $143.84. This leaves the insider owning 3,176 shares of the company worth $0.46 million. Insiders disposed of 1,129,026 shares of company stock worth roughly $165.17 million over the past 1 year. A total of 1.70% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in UHS stock. A new stake in Universal Health Services Inc. shares was purchased by WOODLINE PARTNERS LP during the first quarter worth $28,391,000. PAVADI CAPITAL LLC invested $7,103,000 in shares of UHS during the first quarter. In the first quarter, PEAK6 INVESTMENTS LLC acquired a new stake in Universal Health Services Inc. valued at approximately $4,587,000. AMALGAMATED FINANCIAL CORP. acquired a new stake in UHS for approximately $2,659,000. TREDJE AP-FONDEN purchased a new stake in UHS valued at around $1,952,000 in the second quarter.

Thursday morning saw Universal Health Services Inc. (NYSE: UHS) opened at $145.13. During the past 12 months, Universal Health Services Inc. has had a low of $82.50 and a high of $158.28. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 1.30, and a quick ratio of 1.20. The fifty day moving average price for UHS is $134.08 and a two-hundred day moving average price translates $117.16 for the stock.

The latest earnings results from Universal Health Services Inc. (NYSE: UHS) was released for Sep, 2022. According to the Medical Care Facilities Company, earnings per share came in at $2.54, beating analysts’ expectations of $2.43 by 0.11. This compares to $2.62 EPS in the same period last year. The net profit margin was 5.60% and return on equity was 12.50% for UHS. The company reported revenue of $3.34 billion for the quarter, compared to $3.16 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.7 percent. For the current quarter, analysts expect UHS to generate $3.4B in revenue.

Moreover, the firm recently paid out its quarterly dividend on 03/15/2023. Investors who held shares on 03/01/2023 were paid a $0.20 dividend. On an annualized basis, this represents a $0.80 dividend and a 0.55% percent yield. There was an ex-dividend date of 02/28/2023 for this dividend. In terms of dividend payout ratio, UHS is presently at 6.10%.

Universal Health Services Inc.(UHS) Company Profile

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Tags: NYSE:UHSUHSUHS stockUniversal Health Services Inc.

Related Posts

Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?

January 27, 2023

When is the right time to cash out of Matthews International Corporation [MATW] stock?

January 27, 2023

Investor Insight: OneWater Marine Inc. (ONEW) Goes Ballistic – Investor Confidence on the Rise

January 27, 2023

Is Atreca Inc. [BCEL] a good investment? Don’t be fooled by its recent momentum

January 27, 2023

The most important numbers to know about Ascent Solar Technologies Inc. (NASDAQ:ASTI)

January 27, 2023

Before You Invest In Harte Hanks Inc. (NASDAQ:HHS), Consider This Metric

January 27, 2023
Next Post

Do futuristic bulls still own Pampa Energia S.A. [PAM] stock?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Can CalAmp Corp. (CAMP) stock recover despite sales dropping?

2 weeks ago

The Goodyear Tire & Rubber Company (GT) Holding Strong: What’s pushing it?

2 months ago

Does Fangdd Network Group Ltd. (NASDAQ:DUO) warrant a purchase right now? What to Consider Before Making a Decision

22 hours ago

There has been a significant shift in the fundamentals for Nuveen Municipal High Income Opportunity Fund (NYSE:NMZ)

4 weeks ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch